Equities

Cooper Companies Inc

Cooper Companies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)111.10
  • Today's Change0.57 / 0.52%
  • Shares traded987.90k
  • 1 Year change+31.98%
  • Beta0.9750
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy6
Outperform6
Hold8
Sell0
Strong Sell0

Share price forecast in USD

The 14 analysts offering 12 month price targets for Cooper Companies Inc have a median target of 115.00, with a high estimate of 125.00 and a low estimate of 95.09. The median estimate represents a 4.04% increase from the last price of 110.53.
High13.1%125.00
Med4.0%115.00
Low-14.0%95.09

Earnings history & estimates in USD

On Aug 28, 2024, Cooper Companies Inc reported 3rd quarter 2024 earnings of 0.96 per share. This result exceeded the 0.91 consensus of the 15 analysts covering the company and exceeded last year's 3rd quarter results by 14.56%.
The next earnings announcement is expected on Dec 05, 2024.
Average growth rate+3.61%
Cooper Companies Inc reported annual 2023 earnings of 3.20 per share on Dec 07, 2023.
Average growth rate+3.09%
More ▼

Revenue history & estimates in USD

The Cooper Companies, Inc. had 3rd quarter 2024 revenues of 1.00bn. This bettered the 997.30m consensus of the 13 analysts covering the company. This was 16.81% above the prior year's 3rd quarter results.
Average growth rate+1.93%
The Cooper Companies, Inc. had revenues for the full year 2023 of 3.59bn. This was 8.61% above the prior year's results.
Average growth rate+8.41%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.